COO vs NGNE · P/E 36, rev $4.09B vs $286.5M cap
The Cooper Companies, Inc (COO) versus Neurogene Inc (NGNE) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
COO currently screens at market cap $14.92B and trailing P/E 36.1. NGNE currently screens at market cap $286.5M.
Not investment advice. Open the COO and NGNE stock pages for the full models.
Not investment advice.